Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Colorcon
Express Scripts
Boehringer Ingelheim
Medtronic

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Litigation Details for SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC. (D.N.J. 2019)


Email this page to a colleague

« Back to Dashboard

SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC. (D.N.J. 2019)

Docket ⤷  Free Forever Trial Date Filed 2019-09-30
Court District Court, D. New Jersey Date Terminated 2020-05-12
Cause 35:271 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties BAUSCH HEALTH IRELAND LTD.
Patents 10,456,384; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,741,904; 8,835,452; 8,853,231; 9,271,968
Attorneys CHARLES H. CHEVALIER
Firms Eric I. Abraham
Link to Docket External link to docket
Small Molecule Drugs cited in SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC. (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-09-30 1 Complaint of United States Patent Nos.7,045,620 (the “’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275…infringe one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275…to the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275 External link to document
2019-12-15 15 Amended Complaint the “’231 patent”); 9,271,968 (the “’968 patent”); and 10,456,384 (the “’384 patent”) (collectively, …8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 by submitting ANDA No. 213713 seeking FDA approval…8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 under 35 U.S.C. §§ 271(a), (b), (c), and/or (…8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 remain valid and enforceable; …8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384, inclusive of any exclusivities and extensions External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
McKesson
McKinsey
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.